SCHEMBL2301673

SCHEMBL2301673

CCCCOC(=O)NC=CCCC(=O)O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX2 P34913 3/20 0.50
TERT O14746 3/20 0.41
PTPN1 P18031 3/20 0.41
PPARG P37231 3/20 0.41
PPARD Q03181 3/20 0.41
PPARA Q07869 3/20 0.41
MAPT P10636 2/20 0.41
BLM P54132 2/20 0.41
HSD17B10 Q99714 2/20 0.41
FABP4 P15090 2/20 0.41
F7 P08709 2/20 0.41
F3 P13726 2/20 0.41
ATM Q13315 2/20 0.41
TOP1 P11387 2/20 0.41
GMNN O75496 1/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
CYP1A2 P05177 1/20 0.41
POLB P06746 1/20 0.41
CYP2C9 P11712 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6571002 0.92 EPHX2 (0.56) EPHX2TERTPTPN1PPARGPPARD
SCHEMBL1029105 0.90 EPHX2 (0.64) EPHX2TERTPTPN1PPARGPPARD
SCHEMBL7449007 0.84 EPHX2 (0.49) EPHX2MAPTBLMHSD17B10ATM
SCHEMBL2946547 0.79 EPHX1 (0.44) ATMEPHX1
SCHEMBL7789634 0.77 CTSK (0.55) LMNACYP1A2CYP2C19RECQLKMT2A
SCHEMBL9956131 0.77 HCAR2 (0.58) MAPTATMNPSR1EPHX1
SCHEMBL28397108 0.76 EPHX1 (0.48) ATMEPHX1
SCHEMBL6170813 0.76 ACHE (0.39) EPHX2ATMEPHX1
SCHEMBL6171676 0.76 EPHX2 (0.40) EPHX2ATMEPHX1
SCHEMBL6171271 0.76 HPGD (0.41) EPHX2ATMEPHX1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011100401-A1 MACROCYCLES AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2011-08-18 WO disclosed
WO-2004026293-A2 HEMIASTERLIN DERIVATIVES FOR TREATING RESISTANT TUMORS WYETH HOLDINGS CORPORATION (US) 2004-04-01 WO disclosed